Scientists led by Michael Kastan, MD, PhD, head of the Duke Cancer Institute in Durham, North Carolina, have discovered that cells taken from A-T children are abnormally sensitive when deprived of nutrients such as glucose, glutamine and oxygen. With a grant from the A-T Children’s Project, the team will now study metabolic stress pathways in A-T to determine if metabolic abnormalities are responsible for the brain deterioration and lung problems of A-T. The goal of this project, which is co-funded by the Wobbly Feet Foundation, is to identify proteins in these pathways that, when influenced by drugs, may alleviate many of the devastating symptoms of A-T.
Oops! We could not locate your form.
Related News
Feb 24, 2026Mar 5 @ 12:17 pm
Lost Cleveland Memories’ 500th Presentation for the A-TCP!
Dennis has turned his love of history and storytelling into Lost Cleveland Memories, an incredibly successful fundraising effort
more
Feb 6, 2026Mar 5 @ 12:17 pm
Race with the A-T CureTeam at Disney!
Announcing the CureTeam's Walt Disney World race schedule!
more
Jan 29, 2026Mar 5 @ 12:17 pm
Disappointing Results from Quince’s Clinical Trial of eDSP in A-T
Quince Therapeutics reports topline results from their Phase 3 “NEAT” trial in A-T.
more
Jan 21, 2026Mar 5 @ 12:17 pm
Press Release about Intrabio’s A-T Trial Results
IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.